Dexcom Inc DXCM

$85.36 -0.87 (-1.01%)

Valuation

Market cap
32,211,536,000
Revenue TTM
$4,662,000,000
Net income TTM
$836,300,000
PE ratio
33.82
Forward PE
32.60
Profit margin
17.94%
Debt to equity
0.47

Trading

Volume
2,204,300
Avg volume
4,580,146
Day's range
$84.80 – $86.67
Shares out
377,361,000
Stochastic %K
10%
Beta
1.48
Analysts
Strong Sell
Price target
$93.78

Price

Company profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for...

Show more

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Industry
Medical Devices
Sector
Healthcare
Phone
858 200 0200
Website
https://www.dexcom.com
Address
6340 Sequence Drive, San Diego, United States

Latest news

Stocktwits

iSilenT Sep 30, 3:34 PM
$SENS $DXCM That's where you are wrong. Abbott can raise the prices to whatever they want because Abbott will "work" with insurance companies to make it happen. They can raise the price of 365 to cost the same as 1 year supply of 15 day sensors. Since 15 day sensors are shit, people will move to Eversense 365 if it's readily available and insurance covers it.
1 replies
Merlintrader Sep 25, 10:31 PM
Diabetes: does the best device win the best business? $ABT, $DXCM, $PODD, $SENS https://www.merlintrader.com/diabetes-devices-business-abt-dxcm-podd-sens/
0 replies
quassarcapital Sep 24, 2:53 AM
$DXCM (Dexcom) shares fell 1.1% to close at $87.93 as rising Treasury yields and stronger-than-expected economic data pressured healthcare and tech names heading into Thursday's open.
0 replies
JInvestTrade Sep 23, 4:28 AM
$SENS $DXCM https://youtube.com/shorts/bDRbrrYegxM?si=PiDptqgUXB-zZRHx
0 replies
Cutlass Sep 22, 4:10 PM
$DXCM Hit 90, next up 95 ✍️
0 replies
CmonManGiveMeABreak Sep 22, 3:50 AM
$DXCM oversold and under valued last several years! wtf
0 replies
BuckSlayer Sep 21, 3:21 PM
$ADHC $DXCM Undiscovered goldmine
1 replies
Thelonius_Stonk Sep 20, 11:56 AM
$DXCM looks gud
0 replies